Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04440475 · ClinicalTrials.gov registry record · NA
Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy
A NA study, sponsored by ProMedica Health System.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT04440475 is a NA study that has completed, run by ProMedica Health System. The registered enrollment target is 40 participants.
The verdict
NCT04440475, a NA study, has completed, sponsored by ProMedica Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether the transversus abdominis plane block (Tap block) is different than the oral postoperative pain medications in controlling pain after robotic sacrocolpopexy.
Interventions
- PROCEDURE TAP block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-06-28 |
| Est. Completion | 2022-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04440475
The ClinicalTrials.gov registry entry for NCT04440475 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ProMedica Health System, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TAP block is the first listed.
NCT04440475 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04440475 about?
NCT04440475 is a clinical study titled "Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy". The purpose of this study is to assess whether the transversus abdominis plane block (Tap block) is different than the oral postoperative pain medications in controlling pain after robotic sacrocolpopexy.
What is the current status of trial NCT04440475?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-06-28. Estimated completion is 2022-01-30.
What interventions are being tested in trial NCT04440475?
The interventions under investigation include: TAP block (PROCEDURE).
Who is sponsoring clinical trial NCT04440475?
This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.